Prevalence and pathogenic role of anti-EPO antibodies in patients treated with recombinant erythropoietin

dc.authoridDEMIR, Mehmet/0000-0001-5942-3751
dc.authorwosidDEMIR, Mehmet/AAH-2121-2019
dc.contributor.authorHoppensteadt, DA
dc.contributor.authorTobu, M
dc.contributor.authorChatha, M
dc.contributor.authorBansal, V
dc.contributor.authorMoghaddam, M
dc.contributor.authorSaxena, R
dc.contributor.authorAhmad, S
dc.date.accessioned2024-06-12T11:23:55Z
dc.date.available2024-06-12T11:23:55Z
dc.date.issued2004
dc.departmentTrakya Üniversitesien_US
dc.description56th Annual Meeting of the American-Association-for-Clinical-Chemistry -- JUL 25-29, 2004 -- Los Angeles, CAen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipAmer Assoc Clin Chemen_US
dc.identifier.endpageA54en_US
dc.identifier.issn0009-9147
dc.identifier.issue6en_US
dc.identifier.startpageA54en_US
dc.identifier.urihttps://hdl.handle.net/20.500.14551/26706
dc.identifier.volume50en_US
dc.identifier.wosWOS:000221955200174en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherAmer Assoc Clinical Chemistryen_US
dc.relation.ispartofClinical Chemistryen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keywords]en_US
dc.titlePrevalence and pathogenic role of anti-EPO antibodies in patients treated with recombinant erythropoietinen_US
dc.typeConference Objecten_US

Dosyalar